USA - NASDAQ:RNA - US05370A1088 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to RNA. The Buy consensus is the weighted average rating of the current analysts ratings.
Date | Firm | Action | Rating |
---|---|---|---|
2025-09-15 | B of A Securities | Maintains | Buy -> Buy |
2025-09-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
2025-09-10 | Chardan Capital | Maintains | Buy -> Buy |
2025-09-10 | Needham | Maintains | Buy -> Buy |
2025-08-08 | Chardan Capital | Maintains | Buy -> Buy |
2025-08-08 | Barclays | Maintains | Overweight -> Overweight |
2025-08-08 | Wells Fargo | Maintains | Overweight -> Overweight |
2025-07-10 | Goldman Sachs | Reiterate | Buy |
2025-06-27 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
2025-06-17 | Wolfe Research | Initiate | Outperform |
2025-06-11 | Raymond James | Initiate | Strong Buy |
2025-06-10 | Barclays | Maintains | Overweight -> Overweight |
2025-06-10 | Citigroup | Maintains | Buy -> Buy |
2025-06-09 | Chardan Capital | Maintains | Buy -> Buy |
2025-06-09 | B of A Securities | Maintains | Buy -> Buy |
2025-05-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
2025-05-09 | Chardan Capital | Maintains | Buy -> Buy |
2025-05-07 | Chardan Capital | Maintains | Buy -> Buy |
2025-04-09 | Needham | Reiterate | Buy -> Buy |
2025-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2025-03-17 | Chardan Capital | Maintains | Buy -> Buy |
2025-03-17 | Needham | Reiterate | Buy -> Buy |
2025-03-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
2025-03-13 | Citigroup | Initiate | Buy |
2025-03-12 | BMO Capital | Initiate | Outperform |
2025-03-10 | B of A Securities | Maintains | Buy -> Buy |
2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
2025-02-28 | Chardan Capital | Maintains | Buy -> Buy |
2025-02-28 | Barclays | Maintains | Overweight -> Overweight |
2025-01-21 | RBC Capital | Reiterate | Outperform -> Outperform |